Skip to main content
Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.850
+0.040 (2.21%)
Oct 4, 2024, 4:00 PM EDT - Market closed

Standard BioTools Revenue

Standard BioTools had revenue of $37.21M in the quarter ending June 30, 2024, with 34.48% growth. This brings the company's revenue in the last twelve months to $136.30M, up 29.25% year-over-year. In the year 2023, Standard BioTools had annual revenue of $106.34M with 8.57% growth.

Revenue (ttm)
$136.30M
Revenue Growth
+29.25%
P/S Ratio
2.80
Revenue / Employee
$252,876
Employees
539
Market Cap
686.64M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023106.34M8.39M8.57%
Dec 31, 202297.95M-32.63M-24.99%
Dec 31, 2021130.58M-7.56M-5.47%
Dec 31, 2020138.14M20.90M17.83%
Dec 31, 2019117.24M4.28M3.79%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

LAB News

More News